Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Launched by ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY · Apr 23, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on improving healthcare for people in Kazakhstan who may be at risk of non-communicable diseases (NCDs) such as heart disease, diabetes, and obesity. Researchers are studying how certain biological factors, known as epigenetics, can affect our health and how we can use advanced computer technology (machine learning) to predict biological age and reproductive health. The goal is to create personalized health recommendations that can help prevent these diseases and improve overall well-being.

If you are an adult aged 18 to 69 living in one of the 17 regions of Kazakhstan, you may be eligible to participate in this study. Participants will need to be willing to provide consent and be involved in data collection. Those who join can expect to learn more about their health and receive tailored advice based on their individual needs. It's an opportunity to contribute to important research that could benefit many people in your community.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 to 69 years.
• • Residents of 17 regions of Kazakhstan.
• • Willingness to participate and provide informed consent.
• Exclusion Criteria:
• • Age less than 18 years old or over 69 years old.
• • Failure to provide informed consent or incomplete participation in data collection procedures.